Trial Profile
Comparative, Prospective, Open-labeled, Randomized Phase II Study of Cisplatin or Carboplatin With Gemcitabine in Combination With Irinotecan-loaded Beads (LC or ONCOZENE) Versus Cisplatin or Carboplatin With Gemcitabine Alone
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 25 Aug 2022
Price :
$35
*
At a glance
- Drugs Irinotecan (Primary) ; Carboplatin; Cisplatin; Gemcitabine
- Indications Cholangiocarcinoma
- Focus Therapeutic Use
- Acronyms DELTIC
- 10 Aug 2022 Primary endpoint (The overall response rate) has been met as per results published in the Annals of Surgical Oncology
- 10 Aug 2022 Results published in the Annals of Surgical Oncology
- 17 Aug 2016 Planned End Date changed from 1 Jul 2016 to 1 Jul 2020.